Related Experiment Video
Updated: Jun 11, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases
1Divisions of Global Migration and Quarantine, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Background:
In 1998, the US Centers for Disease Control and Prevention was notified of three patients who developed severe illnesses days after yellow fever vaccination. A similar case occurred in 1996. All four patients were more than 63 years old.
Methods:
Vaccine strains of yellow fever virus, isolated from the plasma of two patients and the cerebrospinal fluid of one, were characterised by genomic sequencing. Clinical samples were subjected to neutralisation assays, and an immunohistochemical analysis was done on one sample of liver obtained at biopsy.
Findings:
The clinical presentations were characterised by fever, myalgia, headache, and confusion, followed by severe multisystemic illnesses. Three patients died. Vaccine-related variants of yellow fever virus were found in plasma and cerebrospinal fluid of one vaccinee. The convalescent serum samples of two vaccinees showed antibody responses of at least 1:10240. Immunohistochemical assay of liver tissue showed yellow fever antigen in the Kuppfer cells of the liver sample.
Interpretation:
The clinical features, their temporal association with vaccination, recovery of vaccine-related virus, antibody responses, and immunohistochemical assay collectively suggest a possible causal relation between the illnesses and yellow fever vaccination. Yellow fever remains an important cause of illness and death in South America and Africa; hence, vaccination should be maintained until the frequency of these events is quantified.
Insights
Severe illness and death occurred in older adults following yellow fever vaccination. Vaccine-related virus variants were identified, suggesting a causal link. Yellow fever vaccination is crucial but requires further safety evaluation in elderly populations.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Reports of severe illness post-yellow fever vaccination in elderly individuals prompted investigation.
- Four cases were identified between 1996 and 1998, all in patients over 63 years old.
Observation:
- Patients presented with fever, myalgia, headache, and confusion, progressing to severe multisystemic disease.
- Three of the four patients ultimately died.
Findings:
- Genomic sequencing identified vaccine-related yellow fever virus variants in patient samples (plasma and cerebrospinal fluid).
- High antibody responses (≥1:10240) were observed in convalescent serum samples.
- Immunohistochemical analysis of liver tissue revealed yellow fever virus antigen in Kupffer cells.
Implications:
- The findings suggest a causal relationship between yellow fever vaccination and severe illness in older adults.
- Yellow fever vaccination remains critical for disease prevention in endemic regions.
- Further research is needed to quantify the frequency of these adverse events in the elderly population.
More Related Videos
Related Concept Videos
Increased Body Temperature
Types of Fever
Here are the different types of fever:
Endocarditis IV: Nursing Management
Diphtheria
Yellow Fever
Hepatitis

